Crescent Biopharma, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $213.2M | $34.8M | $41.8M | $47.9M | $90.3M | $137.0M | $158.2M | $209.9M |
| Accounts Receivable | $18.0M | $0 | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $236.7M | $34.8M | $43.8M | $50.7M | $90.8M | $138.3M | $162.5M | $212.3M |
| Property, Plant & Equipment | $846.0K | $0 | — | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $240.3M | $35.6M | $45.3M | $51.8M | $94.3M | $142.8M | $168.0M | $214.8M |
| Liabilities | ||||||||
| Accounts Payable | — | $329.3K | $868.1K | $970.2K | $2.1M | $2.1M | $1.4M | $2.7M |
| Total Current Liabilities | $36.1M | $9.6M | $6.8M | $8.9M | $11.8M | $12.4M | $11.0M | $8.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $37.3M | $47.1M | $6.9M | $8.9M | $12.7M | $14.6M | $13.8M | $9.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-171.8M | $-17.9M | $-456.5M | $-419.6M | $-372.9M | $-309.5M | $-258.4M | $-200.6M |
| Total Stockholders' Equity | $203.0M | $-15.5M | $38.4M | $42.9M | $81.6M | $128.2M | $154.2M | $205.5M |